Purchases and Sales Made in Q4 2023 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q4 2023. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Sandia Investment Management LP
Boston, MA |
SELL
|
- |
-4.02K- 40.2% |
$38.9K - $61.8K
|
5.98K
$49.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-4.46K- 6.95% |
$43.2K - $68.5K
|
59.7K
$491K
|
|
|
Feb 14, 2024
Q4 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-5.08K- 1.04% |
$49.2K - $78.1K
|
483K
$3.98M
|
|
|
May 21, 2024
Q4 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-6.75K- 40.14% |
$65.3K - $104K
|
10.1K
$82.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-7.36K- 13.44% |
$71.2K - $113K
|
47.4K
$390K
|
|
|
Feb 14, 2024
Q4 2023
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-8.02K- 24.26% |
$77.6K - $123K
|
25K
$206K
|
|
|
Jun 03, 2024
Q4 2023
|
Vontobel Holding Ltd.
|
SELL
|
- |
-8.3K- 34.87% |
$80.3K - $128K
|
15.5K
$128K
|
|
|
Jan 29, 2024
Q4 2023
|
Vontobel Holding Ltd.
|
SELL
|
- |
-8.3K- 34.87% |
$80.3K - $128K
|
15.5K
$128K
|
|
|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-17K- 3.21% |
$165K - $261K
|
513K
$4.22M
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-39.4K- 50.75% |
$381K - $605K
|
38.2K
$315K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-53.6K- 25.1% |
$519K - $824K
|
160K
$1.32M
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-146K- 90.16% |
$1.41M - $2.24M
|
15.9K
$131K
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-249K- 58.66% |
$2.41M - $3.83M
|
176K
$1.45M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-344K- 74.47% |
$3.33M - $5.29M
|
118K
$970K
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-457K- 83.84% |
$4.42M - $7.02M
|
88K
$724K
|
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-550K- 28.42% |
$5.32M - $8.45M
|
1.39M
$11.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-887K- 85.53% |
$8.58M - $13.6M
|
150K
$1.23M
|
|
|
Feb 14, 2024
Q4 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-921K- 41.4% |
$8.92M - $14.2M
|
1.3M
$10.7M
|
|
|
Feb 07, 2024
Q4 2023
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
SELL
|
- |
-1.89M- 86.14% |
$18.3M - $29M
|
303K
$2.5M
|
|
|
Feb 01, 2024
Q4 2023
|
Canaan Partners Xi LLC
Menlo Park, CA |
SELL
|
- |
-2.49MClosed |
$24.1M - $38.3M
|
0
$0
|